PD-L1 Biomarker Testing Market SWOT Analysis, by Key Players

As the prevalence of lung cancer, melanoma, and renal cell carcinoma continues to soar worldwide, the adoption of PD-L1 biomarker testing is expected to grow at a healthy pace in the years to come, says Future Market Insights (FMI) in its new market study. Moreover, the report forecasts that the global PD-L1 biomarker testing market will grow in value at a stellar CAGR of 13.1% between 2020 and 2030.

The report opines that the outbreak of COVID-19 is likely to create short-term fluctuations on the supply side due to pandemic-related issues such as workforce shortages and disruptions of delivery networks. Similarly, a steep decline in the number of tests has been observed during the pandemic, and this is expected to further decelerate the demand for PD-L1 biomarker testing.

The report primarily attributes the growth of the market to the increasing incidence of cancers, especially lung and skin, coupled with the development of advanced diagnostic kits and assays.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5897

Likewise, rising awareness regarding the availability of testing methodology such as immunohistochemistry-based assays and Enzyme-linked Immunoassay (ELISA) based detection will continue to impel the adoption of PD-L1 biomarkers in the forthcoming years.

Key Takeaways

  • The global PD-L1 biomarkers testing market is expected to surge past valuation of US$ 2.05 Bn by the end of the forecast period.
  • PD-L1 SP142 assay kits will remain the most popular products among end-users, capturing nearly half of the market value, owing to high efficiency in detecting cancer tumors.
  • Non-small cell lung cancer and melanoma are cumulatively expected to hold more than 50% of the total market value on the back of the soaring prevalence of these diseases.
  • By end-use, PD-lL1 biomarker testing finds the majority of applications in hospitals, which is expected to account for over 60% of market value.
  • North America will spearhead the regional landscape through the forecast period, accounting for more than 50% of the global market value.
  • Europe is poised to remain the second most lucrative region, holding nearly 1/3rd of market value.

“Market players are directing their efforts towards improving the accessibility of these products and are marking them cost-effective to ensure wide-scale adoption,” remarks FMI analyst.

COVID-19 Impact on PD-L1 Biomarker Testing Market

The COVID-19 pandemic has created disruptions across the healthcare technology landscape and has resulted in a shifting preference among manufacturers towards essential technologies and treatments. Furthermore, although PD-L1 biomarker testing is used to test severe diseases such as cancer, a reduced number of screenings is adversely impacting the demand for testing.

For instance, according to trends observed by Cancer Research Network, screening rates of melanoma plummeted by approximately 50% in the UK in the past few months. Likewise, in the US, the number of tests conducted to detect non-small cell lung cancer fell by 30% in March as compared to February. As patients reschedule or skip regular screenings, this is creating a downtrend in demand for PL-D1 biomarker testing.

However, considering the severity of these diseases, the need for testing will swiftly arise in the future, ensuring that the market’s growth trajectory remains intact.

Who is Winning?

Key players operating in the market are focusing on enhancing existing product designs and developing novel products with increased accuracy. Moreover, traditional growth strategies such as acquisitions and mergers have been identified as strategies adopted by players to strengthen their foothold in the competitive landscape.

  • In January 2019, Abcam Plc acquired Calico Biolabs with an objective to expand its custom monoclonal production service capabilities.
  • In December 2018, NeoGenomics, Inc. acquired Genoptix, Inc. to improve its oncology diagnostic services.

FMI’s report includes profiles of some of the most prominent names in the market including F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., NeoGenomics Laboratories, Inc, HalioDx and Abcam plc. among others.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-5897

To Know More About PD-L1 Biomarkers Market

A new market research report published by Future Market Insights (FMI) on the global PD-L1 biomarkers market offers an executive-level blueprint of the market. It offers insights into demand trends and provides analysis of opportunities over the forecast period, 2020-2030. The report examines the market through four different segments – product, indication, end-use, and region. The report also provides extensive assessment of pricing by different key market dynamics, life cycle analysis, and technologies that are being deployed in the supply and product adoption across several end-use industries.

Optical Coherence Tomography Market Trends, Business Outlook 2020, Expanding Current Industry Status by Top Most Players 2031

ESOMAR-certified consulting firm Future Market Insights’ report, projects a healthy growth, for optical coherence tomography (OCT) market. As per the report, the market is forecast to reach a valuation of US$ 1349.09 Mn over the forecast period of 2021 and 2031.

Growing application of OCT in ophthalmology across China, the U.K., Germany and Japan will bolster the demand of optical coherence tomography across the globe.

As per the FMI’s analysis, the optical coherence tomography market across Japan and China is anticipated to expand at over 9.8% and 4.6%, respectively in 2021. Growing prevalence of eye related disorders such as diabetic retinopathy, glaucoma and others will improve the adoption of OCT imaging systems.

Development of advanced OCT imaging systems coupled with increasing government & private organizations initiatives for eye care programs across the globe are propelling the adoption of OCT imaging systems.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3362

Growing awareness and increasing innovation for the advanced OCT devices for the treatment of skin cancer and eye diseases have urged the manufacturers to incorporate real-time data for better outcomes, expanding their existing product ranges.

Based on the aforementioned factors, the OCT market is slated to expand at a robust pace of over 6.7% CAGR during the assessment period of 2021 and 2031.

Key Takeaways from FMI’s Optical Coherence Tomography Market Study

  • Hospitals are anticipated emerge as primary end users of optical coherence tomography market, accounting for leading market share
  • Preference for spectral domain-OCT will be higher as compared to swept source-OCT over the forecast period
  • Increasing application of OCT in ophthalmology is expected to drive sales through 2031
  • Germany and the U.K. will lead the Europe’s optical coherence tomography market on the back of rising cases of eye disorders across the region
  • Japan is anticipated to emerge as a lucrative market backed by the rising development of advanced OCT imaging systems within healthcare sector
  • China is anticipated to lead the East Asia market during the forecast period, accounting for over 4.6% market sales
  • The U.S. is estimated to be the largest market for optical coherence tomography market attributed to be growing prevalence of eye related disorders

“Key players are increasing research and development activities for the development of advanced OCT imaging system for the early detection & treatment of eye-related disorders. This, in turn, is likely to omprovegrowth opportunities for the market players over the coming years,” says the FMI analyst. 

Optical Coherence Tomography Market Competitive Landscape

Future Market Insights, in its updated report, have profiled prominent players operating in optical coherence tomography market which include Leica Microsystems, Optovue Inc., Carl Zeiss Meditec AG, Santec Corporation, Heidelberg Engineering GmbH, Optopol Technology SP Z.O.O., Topcon Corporation, Michelson Diagnostic Ltd., Tomophase Inc., Moptim Imaging Technique, NIDEK Co. Ltd., and Sonostar Technologies Co. Ltd among others.

Optical coherence tomography systems manufacturers are actively focusing on expanding their product portfolios to improve their revenue generation.

Incorporation of advanced technology combined with the upgradation of its existing range of products is also one of the core strategies of market players to maintain their position in the industry.

The global optical coherence tomography market is dominated by top tier-1 market players that include Leica Microsystem (Sub. Danaher), Optovue Inc., and Zeiss Group (Carl Zeiss Meditec AG).

Targeted mergers and collaborations with top distribution channel partners is anticipated to be the key strategy to maintain their top position in the industry. Around 20% to 25% of global market revenue is contributed by the tier-1 players over the forecast period.

New product launches with the expansion of their existing product range is one of the common market strategy for the key players. For instance:

In March 2021, Premier Medical Imaging AI Inc., a medical technology company focusing to transform cancer surgery with ultra-high resolution, announced the 510 (k) clearance for its Perimeter’s Optical Coherence Tomography imaging system (v2.1) from the U.S. Food & Drug Administration (FDA), designed to examine tissue microstructures during surgical procedures.

In January 2021, Notal Vision announced the launch of its first ‘US Home-Based’ optical coherence tomography platform which was patient self-operated.

To gain more insights into the market with a detailed table of content and figures, click here:  https://www.futuremarketinsights.com/toc/rep-gb-3362

More Insights on the Global Optical Coherence Tomography Market

Future Market Insights, in its latest report, offers an incisive coverage on the global optical coherence tomography market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is classified on the basis of product type (spectral domain-OCT, swept source-OCT, and others), application type (ophthalmology, dermatology, cardiovascular, dental, and others), and end user (hospitals, ophthalmology clinics, dermatology clinics, dental clinics, ambulatory surgical centers, and others) across seven major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)

Global Femtech Market – Notable Developments, Upcoming Trends & Future Applications 2031

Femtech is a term used for female technology which involves the use of digital health tools including software, diagnostics, products, and services that are targeted at women’s health. According to a recent Future Market Insights (FMI) report, the global femtech market is estimated to hit a valuation of US$ 948.1 Mn in 2021, with a market CAGR of 15.0% during the forecast period (2021-2031).

Market demand is set to rise at a steady pace throughout the forecast period, majorly favoured by investments outside the boundaries of healthcare towards a branched approach involving domains such as workplace regulations, financial equity, and state legislation.

The primary factor supporting the femtech market to positive expansion in terms of growth and stability is the advent of digitalization and artificial intelligence. Technological advancements such as cloud-based informatics allow personalized solutions, driven by consumer input. This has given rise to affordable and accessible analysis in terms of personal health monitoring and diagnosis.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11761

Key market players have pushed for innovation and accessibility into customized digital solutions. This also includes the introduction of hands-free wearables which are assistive with the regular, day-to-day life of women across the globe.

Additionally, leading product developers in the femtech market work through commercial partners such as department stores, big-box retailers, hospitals, clinics, insurance companies, pharmacies and drugstores, private medical practices and e-commerce platforms to expand product sales prospects.

Key Takeaways from Femtech Market Study

  • Menstrual health applications will drive market growth holding around a third of the market, supported by growing purchases from the working women demographic.
  • Diagnostic services are projected to cover about 45% of the global market by 2031. This is aided by the growing accessibility of digital health services
  • The U.S. holds a dominant share, valuing at over US$ 357.1 Mn by the end of 2021, supported by the presence of leading players and higher consumer acceptance.
  • The U.K. and Germany dominate the Europe market, cumulatively accounting for more than 25% of the regional revenue.
  • China is a leading market in East Asia, and is forecast to account for more than 50% of the regional value share owing to a vast consumer base.

“The advent of technological improvements in healthcare in the form of devices, applications, services, and products has increased the rate of diagnosis of reproductive disorders in terms of time management and treatments for women. This will aid growth through the upcoming decade,” says the FMI Analyst

Who is Winning?

Some of the leading companies operating in the femtech market are focusing on collaborations with leading institutions for increasing awareness among the population about the adoption of digital health services.

Collaborations with key pharmaceutical companies to launch customized products and services for the growing consumer base has led key players to retain their position in the market while expanding their product portfolio.

  • Research collaboration in monitoring fetal heart rates through wearable ECG chips by between Bloomlife and Imec in 2019 has expectantly given rise to superior monitoring capabilities in maternity care.
  • Femtech companies have integrated applications for tracking fertility and offer services such as in-vitro fertilization. Additionally, they also offer medical treatments and products such as wearables and hands-free devices.

Key market players covered by FMI include Clue, Aparito Limited, Bloomlife, Bonzun Health Information AB, Elvie, Ava Science Inc., Grace Health, iBreve, LactApp, Natural Cycles Nordic AB, Hera Med Ltd., Niramai Health, NURX Inc., SteadySense GmbH, Pregnolia AG, Willow, WOOM and B-wom.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-11761

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global femtech market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the femtech market based on service (diagnostics, monitoring, therapeutic), application (general health and wellness, maternity care, menstrual health, pelvic and uterine healthcare, cancer and chronic disease), and end-user (direct-to-consumer, hospitals, surgical centres, fertility clinics, diagnostics centres) across seven major regions.

Foley Catheter Market Potential Growth, Share, Demand And Analysis Of Key Players- Analysis Forecasts To 2030

The prevalence of urological diseases – such as urinary retention, benign prostate hyperplasia (BPH), bladder obstruction, urinary incontinence, and prostate cancer – has witnessed a significant uptick in the recent past. According to the statistics of the Centers for Disease Control and Prevention (CDC), nearly 15-25% of hospitalized patients receive a urinary catheter annually. As the number of hospital admissions continues to rise year-on-year, there is a persistent need for foley catheters in hospitals, which are projected to remain a crucial end-use segment.

Likewise, the growing burden of urinary retention, a chronic condition in which individuals cannot voluntarily urinate, is propelling demand for foley catheters to facilitate easy drainage of urine. As per the estimates of the American Academy of Family Physicians (AAFP), approximately 4.5 to 6.8 per 1,000 men in the US suffer from urinary retention. As the incidence of disorders continues to grow across the world, the demand for foley catheters is poised to remain high for the years to come.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7769

Along similar lines, the high prevalence of urinary incontinence, a condition that causes the urine to leak involuntarily, is projected to bestow remunerative opportunities to players in the foley catheters market. The severity of urinary incontinence rises with age, with men above 70 being the most affected. The expanding base of the geriatric population will continue to necessitate the usage of foley catheters.

Having analyzed and scrutinized all the aforementioned facets in its new market study, Future Market Insights (FMI) projects that the global foley catheters market will grow in value at a CAGR of nearly 5% between 2020 and 2030. Some of the key takeaways from the report include:

  • The global foley catheters market is expected to surge past valuation of US$ 2.2 Bn by the end of 2030.
  • By product type, 2-way foley catheters are poised to remain the most sought-out variants, owing to their wide availability and simple installation, and will hold more than half of the overall market value.
  • Among materials, latex-based foley catheters are expected to gain an edge over their counterpart, silicon-based foley catheters, backed by their ability to reduce urethral irritation.
  • Based on indication, urinary incontinence is expected to remain the largest segment, on the back of high incidence among geriatric population.
  • North America will remain at the forefront of the regional landscape ascribed to high expenditure on medical aids coupled with new product approvals.
  • Asia Pacific and Europe will continue to bestow remunerative opportunities to market players.

“With catheter-acquired infections being a major challenge to the adoption of foley catheters, manufacturers are focusing on developing products with materials and coatings that aid in reducing accumulation of bacteria, thus restraining the possibility of catheter-acquired infections among patients” remarks FMI analyst.

COVID-19 Impact on Foley Catheters Market

COVID-19 is expected to create slight fluctuations in the growth trajectory of the foley catheters market. There has been a notable shift in priorities of healthcare institutions, with treatment for COVID-19 patients being the utmost priority across the world. Hospitals in severely affected nations such as the US and India have deprioritized non-essential hospitalizations, leading to a downfall in the demand for foley catheters. With urology not being the most concerning healthcare issue currently, the sales of numerous urology care devices, including foley catheters are likely to witness a decline across hospitals. However, the demand for foley catheters in long-term care facilities is poised to remain unhinged through the pandemic, and will continue to drive the sales of these devices.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7769

Who is Winning?

Major players in the market are focusing on developing advanced catheters that reduce the likelihood of the patient developing catheter-associated infections. To achieve the same, they are using novel materials and coatings, and are seeking approvals to commercialize their devices. On these lines,

  • C.R Bard is using silver-ion and antimicrobial coatings in the production of foley catheters to eliminate the risk of catheter-associated infections when used for long periods.
  • B. Braun Melsungen AG continues to develop its catheter product line named Actreen® catheters, designed specifically for urinary retention, and are coated with lubricants to make it comfortable and hygienic to use.
  • In 2019, Safe Medical Design Inc., procured FDA approval to commercialize its new catheter designed to reduce to urethral trauma.

FMI’s report includes profiles of some of the most prominent names in the market including Teleflex Incorporated, Cardinal Health, C.R Bard, B. Braun Melsungen AG, Coloplast A/S, Medtronic plc, Flume, ConvaTec Group, VOTG Medical, Sterimed Group, Ribbel International Limited, Angiplast Private Limited, Mais India Medical Devices Private Limited, and JK Medirise.

Adhesive Films Market Growth Analysis, Varieties And Analysis Of Key Players – Forecasts To 2030

The global adhesive films market is expected to witness a steady CAGR of 5.5% during 2020-2030, according to a new report by ESOMAR-certified market research firm Future Market Insights (FMI).

FMI has revised the projection of the adhesive films market, considering the COVID-19 induced sluggishness in automotive industry. Although a recovery is expected in 2021, the rebuilding process will impact demand for adhesive in general, and adhesive films in particular.

According to FMI, the growth of the adhesive films market will be heavily reliant on the post-pandemic recovery in automotive sector. Demand is likely to remain subdued in the next couple of years, however, FMI opines pre-pandemic level growth rates to be witnessed again in the latter part of this decade.

In addition to the automotive industry, waning demand from construction industry has led to market correction. Infrastructure projects around the globe have been stalled, and new home purchases are at unprecedented lows. However, the long-term outlook on the construction industry remains positive, and adhesive film manufacturers will be hoping for a quick recovery.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12371

Key Takeaways from Global Adhesive Films Market Study

  • Demand for labels across industries to determine success of adhesive films between 2020 and 2030
  • Automotive sector to emerge as the leading end user globally
  • Pace of construction industry recovery to determine adhesive films market growth
  • Asia Pacific to emerge as the leading regional market with emerging economies thriving with manufacturing activities

The demand for adhesive films from the food packaging industry will continue to soar in the coming days as global economy witnesses a shift in consumption patterns.

The longer shelf life of packaged and frozen food become its unique selling point during the lockdowns. Growing sales have resulted in high demand for packaging solutions, which in turn fuelled the demand for adhesive films.

Analysts anticipate as the COVID-19 pandemic continues to wreak havoc it will push people to opt for packaged food, which is an essential and a means of staying indoors. Thus, food packaging industry is expected to give this market a definitive boost in the near future.

“The adhesive films market was growing at a brisk pace, however, the COVID-19 has stalled growth. The lack of momentum has been compensated, to an extent, by growing demand from food packaging industry” says FMI analyst.

Impact of COVID-19 on Adhesive Films Market

The impact of COVID-19 can be felt on the global adhesive films market. As automobile companies witnessed waning sales in the first and second quarter of 2020, it resulted in a massive drop of revenue for the adhesive films market.

Similarly, the market suffered as air travel faced bans and halts, reducing the need for repairs and maintenance altogether. Furthermore, no new contracts and no end in sight to allow travel fully have continued to impact the usage of adhesive films in the aerospace industry.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-12371

Global Adhesive Films Market Report

Future Market Insights, in its new report, offers an unbiased analysis of the global adhesive films market, analysing historical demand from 2015-2019 and forecast statistics for 2020-2030. The study reveals growth projections on the adhesive films market on the basis of material (BOPP, PE, PVC, PA and Others), adhesive type (acrylic, rubber, and silicone), and application (labels, tapes, and graphic films), by end use (electrical and electronics, building and construction, aerospace, automotive, packaging, transportation, and others), and region (North America, Latin America, Europe, the Middle East and Africa, East Asia, South Asia, and Oceania).

 

Medical Hyperspectral Imaging Market – Global Briefing, Growth Analysis And Opportunities Outlook 2021 To 2030

The global medical hyperspectral imaging market will reach nearly USD 300 million by 2030, according to a new market research study by Future Market Insights (FMI), an ESOMAR-certified firm.

Growing number of healthcare ailments continues to drive advancements in medical imaging landscape. As such, computational power, image analysis, and hyperspectral cameras are the technological innovations being implemented all across the healthcare industry.

Non-invasive diseases as well as surgeries are being precisely figured out by imaging sensors. Also, they do not emit any sort of radiation to harm the patient or operator. According to FMI’s analysis, these factors will provide impetus to the market during the assessment period.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12369

Key Takeaways

  • Hyperspectral camera holds the largest market share owing to latest advancements with respect to sensor development
  • High preference for accuracy to boost prospects of MHSI in healthcare
  • US and Europe to collectively account for nearly 40% revenue share
  • India’s growth as a medical tourism hub to create opportunities for market players

“Proven success in North America and Europe is prompting medical hyperspectral imaging market players to shift their priorities to the developing economies. This factor will help in growth of the market between 2020 and 2030” – FMI Analyst

Although FMI’s report is bullish on the use of hyperspectral imaging in medical applications, initial investments and reluctance to experiment will lead to limited adoption, especially in the next couple of years.

FMI’s discussion with stakeholders across the value chain revealed that concerns related to data storage, and the subsequent associated cost has been a key restraint for end-users. Many providers are offering cloud-based storage options, and it is likely that over the course of the forecast period, adoption will gradually increase.

Hyperspectral imaging used in a range of sectors apart from healthcare. The key hyperspectral imaging players are continuously focusing on offering technologically-superior products, not just for the healthcare industry.

According to FMI, holistic advances in hyperspectral imaging will boost the confidence of healthcare industry and fuel adoption. However, manufacturers will need to maintain that elusive balance between quality offerings and competitive pricing.

Key Participant Insights

The global MSHI market exhibits higher growth potential along with entry of new players.

The players have been concentrating on offering software/accessories for further strengthening the market’s competitive environment.

The competitive factors include product differentiation, technology and image software upgrading, on-site and online servicing, and competitive pricing.

The players in the medical hyperspectral imaging market include IMEC, Norsk Elektro Optikk, Galileo, Gilden Photonics, Resonon, XIMEA, Gooch & Housego, Chemlmage, Applied Spectral Imaging, Cubert, EVK DI Kerschhaggl, Headwall Photonics, and FluxData.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12369

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global medical hyperspectral imaging market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on medical hyperspectral imaging market on the basis of product type (healthcare hyperspectral cameras, accessories), application (medical diagnostics (ophthalmology, wound diagnostics, oncology, GI Diseases, others)), tissue and cell biology, drug discovery, others), technology (Visible Hyperspectral Imaging, Near-Infrared Hyperspectral Imaging, Ultraviolet Hyperspectral Imaging, Short-Wave Infrared Imaging, and Mid-Wave Infrared Hyperspectral Imaging), end-user (diagnostic centres, hospitals, research & academic centres, pharmaceutical & biotechnology companies) across seven regions.

 

Anatomic Pathology Market Anticipated Forecast 2030 In Key Regions Global (United States, European Union And China)

The global anatomic pathology market is set to reach USD 58 billion in revenues by 2030, according to a new market study by ESOMAR-certified market research firm, Future Market Insights (FMI).

The anatomic pathology market is subject to integrating medical informatics standards to meet specific healthcare requirements by curtailing costs and improvising on efficiency.

Pathology laboratories are on the verge of refurbishment as new-fangled disease diagnostic models are making a beeline therein.

As of now, lymphoma, breast cancer, colorectal cancer, prostate cancer, cervical cancer, and lung cancer are a part of anatomic pathology.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12370

Key Takeaways

  • The instruments are subject to technological advancements, which would minimize errors. This factor is expected to drive the anatomic pathology market between 2020 and 2030
  • Consumables are expected to hold the largest market share due to low cost, high availability, and good purchase rate of probes and reagents
  • Academic research is bound to pick up pace in the forecast period owing to growing implementation of anatomic pathology in biomarker profiling and tumor examination
  • Preference to personalized therapies is prompting putative biomarkers being discovered. This factor is expected to be one of the key growth drivers

“The anatomic pathology market is witnessing a continuous upswing on the part of biomarkers. This factor is expected to propel the development of anatomic pathology market” – says the FMI analyst.

Key Participant Insights

The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.

For instance –

  • In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.
  • In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest’s infectious disease testing services.
  • In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.

The other players in the veterinary imaging market include Laboratory Corporation of America Holdings, Sakura Finetek USA, Inc., F.Hoffmann-La Roche AG, Cardinal Health, Inc., BioGenex, NeoGenomics, and Agilent Technologies.

The US continues to be one of the leading markets for anatomic pathology market globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology market during the assessment period.

The Europe anatomic pathology market is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.

Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12370

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global anatomic pathology market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on anatomic pathology market on the basis of product & services type (Instruments (Microtomes & Cryostat, Tissue processors, Automatic Stainers, and Other products), consumables (Reagents & Antibodies, Probes & Kits, and Others), application (Disease Diagnosis, Drug Discovery and Development, and Others), and services (histopathology, cytopathology)) across seven geographies.

 

Global Fungal Testing Kits Market Will Reach US$ 3.4 Bn By 2030

Growing prevalence of superficial and systemic fungal infections have posed a significant challenge to healthcare providers across the world. Increasing prevalence of fungal infections of the skin, vagina and blood have prompted vendors to concentrate on developing swift and advanced molecular diagnostics in recent years.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12418

Techniques such as real-time testing have led to massive proliferation of the fungal testing kits market, with technologies such as loop mediated isothermal amplification coming to the forefront. Molecular diagnostic based tests have immensely assisted in administering timely treatment to severely infected patients, thereby reducing fatalities.

In light of these developments, ESOMAR-certified consulting firm Future Market Insights opines that the global fungal testing kits market will reach US$ 3.4 Bn by 2030, registering an incremental opportunity worth US$ 2.1 Bn throughout the forecast period.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-12418

Fungal Testing Kits Market- Key Takeaways

  • Widening expenditure on healthcare infrastructure to uplift demand across Asia-Pacific
  • Molecular detection tests to tower over others, reaching US$ 1.6 Bn by 2030
  • Skin samples are anticipated to capture the lion’s share, accounting for over 40% of the market
  • Medical diagnosis to remain core application area, generating an attractiveness index of 2.8

“Sustained focus on incorporating technological advancements to improve diagnostic outcomes remains the core objective of fungal testing kits manufacturers, enabling them to widen their revenue pools,” infers the FMI analyst.

COVID-19 Impact Insights

The novel coronavirus pandemic has led the entire world into doldrums. With a massive uncertainty looming large over people’s heads, a major economic downturn is on the cards. In spite of this, the healthcare industry remains stoic, committed to eradicate the pandemic as soon as possible.

Future Market Insights projects the fungal testing kits market to register minor shortfalls in the short-term, pegging the slowdown to a rate of 1.1%. Short-term supply crunches were experienced in the initial months, attributed to logistical curbs. However, online marketing helped restore the growth trajectory.

Recent studies have concluded that demand for fungal testing kits are anticipated to surge due to rising cases of COVID-19 associated pulmonary aspergillosis (CAPA). Thus, a minor setback is expected for the market in the short-run, after which projections are expected to return to normal.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-12418

Competitive Intelligence

Prominent players include Merck KGaA, Thermo Fisher Scientific, bioMerieux SA, ELITech Group, PerkinElmer Inc., GenMark Diagnostics Inc., Norgen Biotek, C.P.M Diagnostic Research SAS, Biomed Diagnostics Inc., PCRmax, F. Hoffman La-Roche Ltd., Hologic Inc and Bioquochem. The market appears to be fairly fragmented in nature.

In May 2019, Thermo Fisher Scientific announced the acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies for US$ 1.7 billion. The acquisition has helped the former enhance its laboratory products and services portfolio.

In 2018, PerkinElmer Inc. announced development of the Quasar C-18 used to compare Clotrimazole HPLC analysis. In February 2020, GenMark Diagnostics Inc. published a pipeline study detailing the effectiveness of a PCR-based digital microfluidics and electrochemical detection system for rapid identification of 15 fungal pathogens.

Covid-19 Diagnostics Market – Global Briefing, Growth Analysis And Opportunities Outlook 2021 To 2030

Strong focus on ‘test & trace’, and growing clamor for mass testing will continue to drive demand for Covid-19 diagnostics in 2020 and beyond, according to a new research by ESOMAR-certified firm Future Market Insights (FMI).

The study provides a long-term outlook on the Covid-19 testing kits market, providing a likely scenario until 2030. Although successful vaccines are likely to be developed by 2021, a growing body of research is suggesting that Covid-19 will become endemic, as is the case with other coronaviruses.

An exponential rise in the number of Covid-19 patients across the globe followed by requirements of rapid diagnostics will continue to drive demand.

As of now, research is being conducted regarding diagnostics as well as treatments. Diagnostics comprise PCR-based tests and serological or antibody testing. Antibody tests are best-suited for checking for herd immunities in recovered patients, whereas PCR tests serve the purpose of early detection of coronavirus.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12366

The healthcare industry is emphasizing on development of immunotherapy, vaccines, cell-based and antiviral therapies. As of May 2020, there were 124 vaccines and 205 diverse therapies under development.

The core areas of research are inclusive of protein-based vaccines, drug re-purposes, antibodies, cell-based therapies, non-replicating viral vectors, and RNA-based vaccines.

Key Takeaways from FMI’s Covid-19 Diagnostics Market Study

  • Molecular assay holds the largest share right now and the trend is expected to continue till the end of 2020. This could be attributed to the fact that molecular assays have been looked upon as a gold standard to detect novel viral infections
  • Diagnostic labs contributed to more than 60% of total market share in 2020’s first quarter

“The number of Covid-infected patients have been increasing at an alarming rate every single day. This is bound to drive the Covid-19 diagnostics market exponentially” – says the FMI analyst.

Key Challenges for Market Players & Researchers

Right now, the challenges faced include lack of information regarding the virus, like genetic information, biologics, duration of immunity in the recovered patients.

Certain treatment options that are expected to be potential game changers include ACE-Mab by Sorrento Therapeutics, HCQ (Hydroxychloroquine and chloroquine), Remdesivir antiviral by Gilead Sciences, and Canakinumab (Ilaris) by Novartis.

Moreover, options like cell-based therapies that involve natural killer cells or Mesenchymal stem cells and plasma therapies are on the verge of providing personalized treatment options.

Key Participant Insights

The key participants are focusing on acceleration of production as well as new product approval phase. For example – Novacyt Group, in Mar 2020, received EUA for 2-hour Covid-19 test. Also, in Apr 2020, CE approval was received by Abbott for IgG serology blood test for Covid-19.

The other players in the market include Veredus Laboratories, Thermo Fisher Scientific, Inc., Quidel Corporation, Perkin Elmer, Inc., Neuberg Diagnostics, Mylab Discovery Solutions Pvt Ltd., Luminex Corporation, Laboratory Corporation of America Holdings, Hologic Inc., Danaher, Cepheid, bioMérieux SA, Altona Diagnostics GmbH, ALDATU BIOSCIENCES, ADT Biotech Sdn Bhd, and 1drop Inc.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-12366

Want more insights?

Covid-19 Diagnostics Market, a new study from Future Market Insights, gives the detailed study about Covid-19 diagnostics from 2020 to 2030 on the basis of product (instruments, reagents and kits), sample type (blood, urine, oropharyngeal & nasopharyngeal swabs), technology (polymerase chain reaction (PCR), serology, point-of-care (POC), ELISA (Antibody or Enzyme-Linked Immunosorbent Assay)), end-use (laboratories, hospitals, diagnostic centers and clinics, and research institutes) across seven prominent regions.

 

Angiography Imaging Systems Market Share, Revenue, And Average Price By Manufacturers Shared In A Latest Research Report

Angiography is the medical imaging technique used to visualize inside the blood vessel and body organ especially arteries, veins, and the heart chambers.  Angiography imaging systems are used to performed angiography. Angiography imaging systems market players continuously develop new technologies to reduce radiation dosage, enable advanced procedural image guidance and improve image quality. Angiography imaging systems manufacturers are focusing on the development of systems for complex and hybrid interventional cath labs procedures. Companies are focusing to introduce several new systems with advanced features. Siemens introduced several new systems such as Artis Q, Artis Q.zen and the Artis one. In 2014, Toshiba introduced its new line of combination CT/angiography systems, these offers all-in-one interventional lab and CT solution. New angiography imaging systems enable advanced 3-D imaging  with rotational angiography. Most recently, Siemens Artis Pheno and Phillips’s Azurion Systems gained U.S. FDA clearance in 2017. In 2017, manufacturer such as Siemens launched combined computed tomography (CT)/ magnetic resonance imaging (MRI) angiography imaging systems. Angiography imaging systems market players are adopting several strategies to grab a strong market place in the global market.  Product launches have one of the major strategies adopted by market players.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-9400

Angiography Imaging Systems Market: Drivers and Restraints-

Angiography imaging systems market is expected to accounts significant growth rate as rising prevalence of cardiovascular diseases. According to World Health Organization, around 17.9 Mn people die each year from cardiovascular diseases worldwide. Increasing high blood pressure cases, high cholesterol and smoking are the major risk of cardiovascular diseases and expected to propel the demand for angiography imaging systems. Growing number of angiography procedures expected to favor the demand of the angiography imaging systems. Rising prevalence of coronary artery diseases and increasing cases blood vessel blockage is expected to propel the growth of the angiography imaging systems market. Increasing aging population, growing healthcare expenditure and investment expected to boost the growth of angiography imaging systems market. Increasing preference of minimally invasive surgical procedures propels the demand for the angiography imaging systems market.

Angiography Imaging Systems Market: Overview

Angiography imaging systems market has inherited with big medical devices manufacturers. These manufacturers are focusing on the development of new angiography imaging systems with advanced features.  Manufacturers are focusing on angiography imaging systems features such as lower radiation dose, enable fusion imaging, boost image enhancement, and feasibility to perform complex surgical and imaging procedures. As well as big market players are expressing interest in the development and introduction of robotic angiography imaging systems. Angiography Imaging Systems Market: Region-wise Outlook

In terms of geography, the market has been divided into seven regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding & Japan (APEJ), Japan, Middle-East & Africa, and Latin America. North America is the most dominating market for angiography imaging systems market due to the growing adoption of advanced angiography imaging systems and the growing prevalence of cardiovascular diseases. Western European expected to contribute the second largest revenue share in angiography imaging systems market. The Asia Pacific excluding Japan angiography imaging systems market is expected to gain a high growth rate over the forecast period due to increasing healthcare expenditure and healthcare infrastructure development.

Angiography Imaging Systems Market: Key Market Participants

Example of some market players participants in global angiography imaging systems market identify across the value chain are Koninklijke Philips N.V., Siemens AG, Shimadzu Corporation,  Canon Inc., Omega Medical Imaging LLC and others. The angiography imaging systems manufacturer is focusing on the launch of new products for expansion of market presence and revenue growth.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, China ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Angiography Imaging Systems Market: Segmentation

On the basis of technology, angiography imaging systems market can be segmented as:

  • X-Ray angiography
  • CT angiography
  • MRI angiography
  • MR-CT angiography

On the basis of application, angiography imaging systems market can be segmented as:

  • Cardiology
  • Oncology
  • Neurology
  • Peripheral and Vascular Intervention
  • Others

On the basis of end user, angiography imaging systems market can be segmented as:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Cath Labs

 

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9400

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint